Detalhe da pesquisa
1.
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Blood
; 131(25): 2836-2845, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29549175
2.
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
Br J Haematol
; 185(4): 679-690, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30828801
3.
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
Blood
; 129(13): 1791-1801, 2017 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126925
4.
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism.
J Cell Mol Med
; 22(8): 3887-3898, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761849
5.
Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
Int J Cancer
; 139(9): 1915-26, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27299510
6.
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma.
Mol Cancer Ther
; 16(10): 2304-2314, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729399
7.
DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.
J Immunother
; 40(9): 315-322, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961609
8.
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
Sci Transl Med
; 8(368): 368ra171, 2016 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27928025